Evidence map›Paper›PMID 10072405›Full record

ArticleThe Plant cell1999

Stochastic and nonstochastic post-transcriptional silencing of chitinase and beta-1,3-glucanase genes involves increased RNA turnover-possible role for ribosome-independent RNA degradation.

H Holtorf, H Schöb, C Kunz, R Waldvogel, F Meins

Open access · bronzeAbstract read
In one paragraph

Article in The Plant cell, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
15.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 50 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. The rest is silence.RNA (New York, N.Y.) · 2001
    Review
  10. Review
  11. Article
  12. Article
  13. Mutants of Arabidopsis defective in a sequence-specific mRNA degradation pathway.Proceedings of the National Academy of Sciences of the United States of America · 2000
    Article
  14. Review
  15. Post-transcriptional gene silencing mutants.Plant molecular biology · 2000
    Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

H HoltorfFriedrich Miescher Institute, P.O. Box 2543, CH-4002 Basel, Switzerland.
H Schöb
C Kunz
R Waldvogel
F Meins
Friedrich Miescher Institute · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Stochastic and nonstochastic post-transcriptional gene silencing (PTGS) in Nicotiana sylvestris plants carrying tobacco class I chitinase (CHN) and beta-1,3-glucanase transgenes differs in incidence, stability, and pattern of expression. Measurements with inhibitors of RNA synthesis (cordycepin, actinomycin D, and alpha-amanitin) showed that both forms of PTGS are associated with increased sequence-specific degradation of transcripts, suggesting that increased RNA turnover may be a general feature of PTGS. The protein synthesis inhibitors cycloheximide and verrucarin A did not inhibit degradation of CHN RNA targeted for PTGS, confirming that PTGS-related RNA degradation does not depend on ongoing protein synthesis. Because verrucarin A, unlike cycloheximide, dissociates mRNA from ribosomes, our results also suggest that ribosome-associated RNA degradation pathways may not be involved in CHN PTGS.

Indexed as

Plants, ToxicProtein Processing, Post-TranslationalAmanitinsbeta-GlucosidaseChitinasesDactinomycinDeoxyadenosinesGlucan 1,3-beta-GlucosidaseNicotianaRibosomesRNA, PlantAmanitinsbeta-GlucosidaseChitinasescordycepinDactinomycinDeoxyadenosinesGlucan 1,3-beta-GlucosidaseRNA, Plant

Identifiers

PMID10072405
PMCPMC144180
OpenAlexW2126239647

What OpenQuestion holds

Texttitle and abstract
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.